Overview Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes Status: Completed Trial end date: 2021-01-10 Target enrollment: Participant gender: Summary This is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes. Phase: Phase 4 Details Lead Sponsor: Trieu, Nguyen Thi, M.D.